{
    "clinical_study": {
        "@rank": "117758", 
        "arm_group": {
            "arm_group_label": "HRA Device", 
            "arm_group_type": "Experimental", 
            "description": "Patients who will be treated with Ascension HRA device."
        }, 
        "brief_summary": {
            "textblock": "It is a non-randomized, consecutive enrollment, 10-year follow-up study of patients who are\n      treated with the Ascension\u00ae HRA.  Its purpose is to measure and document the outcomes\n      associated with implanting the Ascension HRA prosthesis.  Patients will be periodically\n      assessed to collect data related to safety and effectiveness endpoints at the following\n      intervals: preoperative, surgery/immediate post-op, 3 months, 6 months, 1 year, 2 year, 5\n      year, and 10 years."
        }, 
        "brief_title": "Ascension\u00ae Humeral Resurfacing Arthroplasty Follow-Up Study", 
        "completion_date": {
            "#text": "December 2022", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Shoulder Arthritis Osteoarthritis", 
            "Rheumatoid Arthritis Shoulder", 
            "Acquired Deformity of Head", 
            "Post-traumatic Arthrosis of Other Joints, Shoulder Region"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Arthritis", 
                "Arthritis, Rheumatoid", 
                "Joint Diseases", 
                "Osteoarthritis"
            ]
        }, 
        "detailed_description": {
            "textblock": "At each assessment interval, information on complications and adverse events will be\n      collected.  In addition, shoulder joint range of motion will be collected, and implants will\n      be evaluated radiographically to determine joint position and assess implant with regards to\n      radiolucencies, subsidence and subluxation (migration).  Patient satisfaction with regard to\n      the effect of the implant on shoulder function, joint pain, and overall satisfaction will be\n      assessed using a visual analog scale (VAS).  Furthermore, if there are any implant revisions\n      during the 10-year follow-up for any of the patients enrolled in the study, the implant\n      and/or surrounding tissue will be harvested if possible and submitted for histopathological\n      examination."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The following patient will be included in the study - Patient who:\n\n               -  Is treated with the Ascension HRA;\n\n               -  Is disabled by either non-inflammatory or inflammatory arthritis (i.e.\n                  rheumatoid arthritis, osteoarthritis and avascular necrosis;\n\n               -  Has mild or moderate humeral head deformity and /or limited motion;\n\n               -  Has post-traumatic arthritis;\n\n               -  Has an intact or reparable rotator cuff;\n\n               -  Has the means and ability to return for all required study visits\n\n               -  Is willing to participate in the study;\n\n               -  Has signed an Informed Consent Form;\n\n               -  Is at least 18 years of age and skeletally mature at the time of surgery;\n\n               -  Is less than 75 years of age at the time of surgery\n\n        Exclusion Criteria:\n\n        The following patients will be excluded from the study - Patients who:\n\n          -  Infection, sepsis, and osteomyelitis;\n\n          -  Osteoporosis;\n\n          -  Metabolic disorders which may impair bone formation;\n\n          -  Osteomalacia;\n\n          -  Rapid joint destruction, marked bone loss or bone resorption apparent on X-ray;\n\n          -  Revision procedures where other devices or treatments have failed\n\n          -  Refuses to be in the study; or does not have the means and ability to return for all\n             required study visits;\n\n          -  Currently participating in another clinical study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02029469", 
            "org_study_id": "CP- HRA-001"
        }, 
        "intervention": {
            "arm_group_label": "HRA Device", 
            "description": "Patients who are treated with the Ascension\u00ae HRA for resurfacing of humeral head.", 
            "intervention_name": "Ascension HRA device", 
            "intervention_type": "Device", 
            "other_name": "Ascension Metal HRA device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Humeral Resurfacing", 
            "Humeral Resurfacing Arthroplasty"
        ], 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "contact": {
                "email": "Haven.Rodriguez@va.gov", 
                "last_name": "Haven Rodriguez, RN", 
                "phone": "727-398-6661", 
                "phone_ext": "7681"
            }, 
            "facility": {
                "address": {
                    "city": "Bay Pines", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33744"
                }, 
                "name": "Bay Pines VA Healthcare System"
            }, 
            "investigator": {
                "last_name": "Sam Hakki, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Ascension\u00ae Humeral Resurfacing Arthroplasty Follow-Up Study", 
        "overall_official": {
            "affiliation": "Bay Pines VA Health Care System", 
            "last_name": "Sam Hakki, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2022", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The ASES score will be evaluated at 2 years and compared to baseline.", 
            "measure": "American Shoulder and Elbow Surgeon Score", 
            "safety_issue": "No", 
            "time_frame": "Outcome data will be evaluated at 2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02029469"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Shoulder range of motion will be measured compared to baseline.", 
                "measure": "Range of Motion", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "VAS score for pain will be evaluated at 2 years and compared to baseline.", 
                "measure": "VAS scale for pain", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Radiographs will be evaluated at 2 years for subsidence, lucent lines and evidence of movement or pending failure.", 
                "measure": "AP and axillary radiographs", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "description": "AEs will be assessed at each study timepoint", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "2 years and during entire trial"
            }
        ], 
        "source": "Ascension Orthopedics, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ascension Orthopedics, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2007", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}